Bonesupport Holding AB (publ) (LON:0RQO)

Market Cap	1.51B
Revenue (ttm)	76.94M
Net Income (ttm)	9.43M
Shares Out	n/a
EPS (ttm)	0.14
PE Ratio	160.31
Forward PE	70.00
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,762
Average Volume	32,129
Open	288.80
Previous Close	293.95
Day's Range	287.00 - 289.90
52-Week Range	245.00 - 404.40
Beta	0.66
RSI	59.72
Earnings Date	Jul 15, 2025

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute t...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1999
• Employees: 139
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RQO

Financial Performance

In 2024, Bonesupport Holding AB's revenue was 898.73 million, an increase of 52.05% compared to the previous year's 591.08 million. Earnings were 133.75 million, a decrease of -45.41%.

Financial numbers in SEK